News

Global equity income investors saw dividends leap by 31.4% in the first quarter of 2014, buoyed by special payouts, with the underlying increase rising at the fastest rate since 2012.

Charles Stanley is to offer its model portfolio range via Standard Life's Wrap platform.

Shares in pharma giant AstraZeneca plunged this morning after the group rejected a fresh offer from US firm Pfizer.

The Investment Management Association (IMA) has written to UK fund groups asking them to anonymously disclose details of salary structures following discussions with EU regulators.

Kames Capital is considering a move into the multi-asset absolute return space, following strong inflows into its existing absolute return products and the outstanding success of the multi-billion pound GARS franchise.

AstraZeneca has rejected a new takeover bid by Pfizer, arguing it still undervalues the business.

The number of complaints from self-invested personal pension (SIPP) savers dealt with by the financial Ombudsman rose almost 50% last year, with most gripes linked to recommendations to invest in unregulated investment schemes, according to a report....

The government may "pare back" its Help to Buy scheme if the Bank of England (BoE) believes it threatens the UK's economic recovery, Nick Clegg has said.

National advice firm Chase de Vere has reached a settlement with the Financial Services Compensation Scheme (FSCS) for an undisclosed sum to deal with claims of poor advice in relation to its sale of Keydata products.

Pension savers will be among the targets of Aviva Investors' forthcoming low volatility multi-asset strategy, the firm's head of multi-asset has said.